Dysphagia Knowledge Hub — 吞嚥困難知識庫
Progressive Supranuclear Palsy (PSP) and Dysphagia — Clinical Guide to Swallowing Problems in PSP
TL;DR: Progressive supranuclear palsy (PSP) is a rare atypical parkinsonian disorder in which swallowing problems appear early — a median of about 42 months after the first motor symptom, versus roughly 130 months in Parkinson’s disease. Pooled research puts dysphagia prevalence at 78–89% and instrumental aspiration at about one in four patients. Aspiration pneumonia is the leading cause of death, and once a first pneumonia occurs, mean remaining survival is about 2.3 years. Early, repeated swallowing assessment (VFSS or FEES), texture modification using the IDDSI framework, and proactive advance care planning are the pillars of care.
What is progressive supranuclear palsy?
Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease caused by abnormal accumulation of tau protein in the brainstem, basal ganglia and frontal cortex. It belongs to the “atypical parkinsonian” or “Parkinson-plus” family, alongside multiple system atrophy (MSA) and corticobasal degeneration (CBD).
Key facts:
- Prevalence: a 2023 systematic review and meta-analysis estimated pooled PSP prevalence at roughly 6.9 per 100,000 people, with reported estimates ranging from 1 to 18 per 100,000 depending on methodology (Lyons et al., 2023).
- Typical onset: mid-60s; the Japanese cohort studies report mean onset around 67–68 years (Iwashita et al., 2023).
- Hallmark signs: early unexplained backward falls, vertical gaze palsy (difficulty looking down), axial rigidity, slowed thinking, and personality or behaviour change.
- Diagnosis: the 2017 Movement Disorder Society (MDS) criteria recognise several PSP phenotypes, with Richardson’s syndrome (PSP-RS) the most common and most rapidly progressive (Boxer et al., 2017).
There is currently no disease-modifying treatment. Care is therefore focused on symptom control, complication prevention — above all aspiration pneumonia — and quality of life (Rowe et al., 2021).
How common is dysphagia in PSP?
Dysphagia is not a late or occasional feature of PSP — it is one of the defining clinical problems.
A 2024 systematic review and meta-analysis (Glinzer et al., 12 studies, PROSPERO-registered) found:
- Pooled dysphagia prevalence: 78–89%, depending on the assessment method used (instrumental assessment, clinical swallowing evaluation, screening, or patient-reported measures).
- Pooled aspiration prevalence: 23.5% (95% CI 14.5–33.7) on instrumental testing — and the authors note this proportion likely rises as the disease progresses.
In plain terms: four out of five people with PSP will develop swallowing problems, and about one in four is already aspirating when tested instrumentally. Because PSP is rare, most studies are small, and the true figures in advanced disease are probably higher.
Why does dysphagia start earlier in PSP than in Parkinson’s disease?
The landmark evidence comes from a multicentre clinicopathological study of 83 postmortem-confirmed parkinsonian cases (Müller et al., 2001, Archives of Neurology):
| Disorder | Median latency to dysphagia |
|---|---|
| PSP | 42 months |
| Dementia with Lewy bodies | 43 months |
| Corticobasal degeneration | 64 months |
| Multiple system atrophy | 67 months |
| Parkinson’s disease | 130 months |
Two further findings from that study matter for families:
- Dysphagia within the first year of disease onset had 100% specificity for an atypical parkinsonian disorder — in other words, if someone diagnosed with “Parkinson’s” develops real swallowing difficulty within the first year, clinicians should re-examine the diagnosis.
- Once dysphagia appeared, remaining survival was similarly short across PD, MSA and PSP (15–24 months), and latency to dysphagia correlated strongly with total survival (rho = 0.88). Dysphagia onset is therefore one of the most important prognostic milestones in PSP.
The reason dysphagia comes early is anatomical: PSP tau pathology hits the brainstem swallowing centres and the frontal circuits that plan and initiate movement, whereas Parkinson’s disease predominantly affects the substantia nigra first.
What does swallowing impairment in PSP actually look like?
The largest prospective videofluoroscopic (VFSS) study to date — 51 adults with PSP assessed with the standardised Modified Barium Swallow Impairment Scale (MBSImP) and Penetration-Aspiration Scale (Clark et al., 2020, Mayo Clinic) — paints a distinctive picture:
- Oral-phase problems dominate: a characteristic back-and-forth rocking motion of the tongue, delayed initiation of the pharyngeal swallow, and oral residue after the swallow.
- Pharyngeal problems are present but milder than in many other neurological dysphagias, with two exceptions: reduced tongue-base retraction (causing pharyngeal residue) and mildly disrupted laryngeal vestibule closure (the doorway to the airway not sealing fully).
- About two-thirds of patients reported difficulty with liquids, solids, or both — yet fewer than 15% had modified their food textures, showing how under-recognised and under-managed the problem is.
- Swallowing impairment correlated significantly with overall disease severity on the PSP Rating Scale (oral total r = 0.42; pharyngeal total r = 0.41; thin-liquid penetration-aspiration r = 0.44).
A separate Japanese study of 56 advanced PSP patients (Iwashita et al., 2023) adds a practical risk profile: cognitive decline, axial rigidity, and retrocollis (the neck pulled backward — a classic PSP posture that mechanically opens the airway during swallowing) were the strongest predictors of needing tube feeding. Aspiration seen on the first VFSS significantly shortened the time to tube-feeding dependence.
Aspiration pneumonia — the leading cause of death
Aspiration pneumonia is the most common fatal complication of PSP. The pivotal cohort study (Tomita et al., 2015, PLoS ONE; 90 clinically diagnosed PSP patients followed a mean of 5.1 years) found:
- 22 patients developed aspiration pneumonia; of these, 91% had to discontinue oral feeding entirely and 59% died — versus only 4% mortality in those without pneumonia.
- Time to the first pneumonia correlated almost perfectly with survival (Spearman R = 0.92), with a mean latency of just 2.3 years from first pneumonia to death.
- Independent predictors of pneumonia were early falls (adjusted HR 3.9) and cognitive decline (adjusted HR 5.2) — not reported dysphagia itself, underlining how much aspiration in PSP is silent (no cough, no obvious distress).
This silent-aspiration pattern is why families cannot rely on coughing or choking as warning signs, and why scheduled instrumental assessment matters more than waiting for symptoms.
How is swallowing assessed in PSP?
Current clinical guidance (Rowe et al., 2021, Practical Neurology) recommends proactive, repeated swallowing evaluation rather than waiting for a crisis:
- Baseline instrumental assessment at or soon after diagnosis, then periodic re-assessment — many specialist centres repeat VFSS or FEES roughly every 6 months, or sooner if there is a chest infection, weight loss, or a change in eating behaviour.
- VFSS (videofluoroscopy) shows the oral rocking tongue pattern, delayed swallow initiation, residue and airway invasion described above.
- FEES (endoscopic swallowing evaluation) is a bedside alternative, useful when travel to radiology is difficult or when fatigue limits testing.
- Screening tools such as EAT-10 or a water swallow test can flag risk between instrumental assessments, but a normal screen does not exclude silent aspiration in PSP.
- Watch the non-swallowing red flags: early falls, cognitive decline, axial rigidity and retrocollis all predict faster progression to unsafe oral intake (Tomita 2015; Iwashita 2023).
Managing dysphagia in PSP — what actually helps
There is no medication that meaningfully improves PSP dysphagia; levodopa response is poor in PSP generally. Management is rehabilitative, compensatory and nutritional (Rowe et al., 2021):
- Texture modification with the IDDSI framework. Because pharyngeal residue and impaired airway closure are the core problems, clinicians commonly progress patients from regular food toward IDDSI Level 6 (soft & bite-sized), Level 5 (minced & moist) and eventually Level 4 (puréed), with drinks thickened to the level shown safe on instrumental testing. Retrocollis may require specific positioning work with the physiotherapist and speech-language therapist.
- Compensatory techniques: chin-tuck posture, double swallows, small bolus sizes, alternating sips and bites, and avoiding straws — all individualised after VFSS/FEES.
- Mealtime supervision and pacing. Cognitive decline and impulsivity (a frontal feature of PSP) cause dangerously fast eating and overfilling the mouth; supervised, unhurried meals with small portions are safer.
- Oral hygiene. Meticulous mouth care reduces the bacterial load of any aspirated material and is one of the few interventions with randomised-trial evidence for cutting aspiration pneumonia risk in dependent adults.
- Weight and nutrition monitoring at every visit; involve a dietitian early.
- Feeding-tube decisions. Gastrostomy (PEG) reduces but does not eliminate aspiration risk — saliva can still be aspirated. In the Iwashita 2023 cohort, half of the tube-fed patients had a gastrostomy. Because dysphagia onset marks a limited-survival phase, PEG decisions should be made within advance care planning, weighing comfort, family goals and the overall prognosis rather than as an automatic step.
- Multidisciplinary care: neurologist, speech-language therapist, dietitian, physiotherapist, occupational therapist and palliative care — ideally in a specialist movement-disorder clinic.
PSP vs Parkinson’s disease vs MSA — dysphagia at a glance
| Feature | PSP | Parkinson’s disease | MSA |
|---|---|---|---|
| Median time to dysphagia | ~42 months | ~130 months | ~67 months |
| Dysphagia prevalence | 78–89% | rises with disease duration; ~80%+ in advanced disease | high; within 5 years of motor onset per 2021 consensus |
| Dominant VFSS pattern | Oral-phase impairment, tongue rocking, delayed initiation | Pharyngeal residue, reduced hyolaryngeal excursion | Delayed pharyngeal phase (92%), vocal-fold impairment |
| Silent aspiration | Common | Common in advanced disease | Common |
| Aspiration pneumonia as leading cause of death | Yes | Yes (advanced) | Yes |
| Levodopa response of dysphagia | Poor | Partial | Poor |
(Sources: Müller 2001; Glinzer 2024; Clark 2020; MSA international consensus 2021.)
Common mistakes and pitfalls
- Waiting for coughing or choking before referring. Aspiration in PSP is frequently silent. Refer for instrumental assessment at diagnosis, not after the first pneumonia.
- Assuming “Parkinson’s” timelines apply. A swallowing problem appearing within the first year of a parkinsonian illness is a red flag for an atypical disorder and should prompt neurological review (Müller 2001).
- Ignoring posture. Retrocollis and axial rigidity mechanically compromise the airway; seating and head support are as important as food texture (Iwashita 2023).
- Leaving textures unchanged because the patient “still manages.” In the Mayo cohort, two-thirds reported swallowing difficulty but under 15% had modified their diet (Clark 2020).
- Treating PEG as a cure for aspiration. Tube feeding does not stop aspiration of saliva; frame it as a nutrition decision within advance care planning.
- Skipping oral care. Poor oral hygiene turns every micro-aspiration into a pneumonia risk.
- Delaying advance care planning. With mean survival of ~2.3 years after first pneumonia, goals-of-care conversations should happen early, while the patient can still participate.
Citations and sources
- Glinzer J, Flynn É, Tampoukari E, Harpur I, Walshe M. Dysphagia Prevalence in Progressive Supranuclear Palsy: A Systematic Review and Meta-Analysis. Dysphagia. 2024;39(6):1052–1064. PMID: 38523230.
- Clark HM, Stierwalt JAG, Tosakulwong N, Botha H, Ali F, Whitwell JL, Josephs KA. Dysphagia in Progressive Supranuclear Palsy. Dysphagia. 2020;35(4):667–676. PMID: 31676923.
- Müller J, Wenning GK, Verny M, et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol. 2001;58(2):259–264. PMID: 11176964.
- Tomita S, Oeda T, Umemura A, et al. Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study. PLoS One. 2015;10(8):e0135823. PMID: 26270456.
- Iwashita Y, Umemoto G, Fujioka S, et al. Factors that impact dysphagia and discontinuance of oral intake in patients with progressive supranuclear palsy. Front Neurol. 2023;14:1259327. PMID: 37780702.
- Rowe JB, Holland N, Rittman T. Progressive supranuclear palsy: diagnosis and management. Pract Neurol. 2021;21(5):376–383. PMID: 34215700.
- Lyons S, Trépel D, Lynch T, Walsh R, O’Dowd S. The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis. J Neurol. 2023;270(9):4451–4465. PMID: 37289323.
- Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol. 2017;16(7):552–563. PMID: 28653647.
- International Dysphagia Diet Standardisation Initiative (IDDSI). Framework and testing methods. https://iddsi.org
This article paraphrases publicly-available clinical research and guidelines. For clinical practice, refer to the current official documentation. This page is not medical advice.
Last updated: 2026-10-10 · License: CC BY 4.0 · Maintained by SeniorDeli (Carewells) — a Hong Kong social enterprise producing IDDSI-compliant care food for people living with dysphagia. This page is educational only; see About for our clinical partners and social mission.